344 related articles for article (PubMed ID: 15006706)
21. Clinical and electrophysiological studies of a family with probable X-linked dominant Charcot-Marie-Tooth neuropathy and ptosis.
Wu T; Wang HL; Chu CC; Yu JM; Chen JY; Huang CC
Chang Gung Med J; 2004 Jul; 27(7):489-500. PubMed ID: 15508871
[TBL] [Abstract][Full Text] [Related]
22. Connexin32 mutations associated with X-linked Charcot-Marie-Tooth disease show two distinct behaviors: loss of function and altered gating properties.
Ressot C; Gomès D; Dautigny A; Pham-Dinh D; Bruzzone R
J Neurosci; 1998 Jun; 18(11):4063-75. PubMed ID: 9592087
[TBL] [Abstract][Full Text] [Related]
23. [Two novel mutations of GJB1 gene associated with typical X-linked Charcot-Marie-Tooth disease].
Qiao XH; Li YX; Chang XZ; Luan XH; Chen B; Bu DF; Yuan Y
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(47):3328-31. PubMed ID: 20193560
[TBL] [Abstract][Full Text] [Related]
24. Two novel connexin32 mutations cause early onset X-linked Charcot-Marie-Tooth disease.
Braathen GJ; Sand JC; Bukholm G; Russell MB
BMC Neurol; 2007 Jul; 7():19. PubMed ID: 17620124
[TBL] [Abstract][Full Text] [Related]
25. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.
Omori Y; Mesnil M; Yamasaki H
Mol Biol Cell; 1996 Jun; 7(6):907-16. PubMed ID: 8816997
[TBL] [Abstract][Full Text] [Related]
26. Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation.
Hanemann CO; Bergmann C; Senderek J; Zerres K; Sperfeld AD
Arch Neurol; 2003 Apr; 60(4):605-9. PubMed ID: 12707076
[TBL] [Abstract][Full Text] [Related]
27. Abnormal Schwann cell-axon interactions in CMT neuropathies. The effects of mutant Schwann cells on the axonal cytoskeleton and regeneration-associated myelination.
Sahenk Z
Ann N Y Acad Sci; 1999 Sep; 883():415-26. PubMed ID: 10586265
[TBL] [Abstract][Full Text] [Related]
28. X-linked Charcot-Marie-Tooth disease and connexin32.
Ionasescu VV
Cell Biol Int; 1998 Nov; 22(11-12):807-13. PubMed ID: 10873293
[TBL] [Abstract][Full Text] [Related]
29. Transient leukoencephalopathy associated with X-linked Charcot-Marie-Tooth disease.
Rosser T; Muir J; Panigrahy A; Baldwin EE; Boles RG
J Child Neurol; 2010 Aug; 25(8):1013-6. PubMed ID: 20472869
[TBL] [Abstract][Full Text] [Related]
30. Molecular genetics of X-linked Charcot-Marie-Tooth disease.
Kleopa KA; Scherer SS
Neuromolecular Med; 2006; 8(1-2):107-22. PubMed ID: 16775370
[TBL] [Abstract][Full Text] [Related]
31. Diverse trafficking abnormalities of connexin32 mutants causing CMTX.
Yum SW; Kleopa KA; Shumas S; Scherer SS
Neurobiol Dis; 2002 Oct; 11(1):43-52. PubMed ID: 12460545
[TBL] [Abstract][Full Text] [Related]
32. Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X.
Kyriakoudi S; Sargiannidou I; Kagiava A; Olympiou M; Kleopa KA
Hum Mol Genet; 2017 May; 26(9):1622-1633. PubMed ID: 28334782
[TBL] [Abstract][Full Text] [Related]
33. Altered assembly of gap junction channels caused by COOH-terminal connexin32 mutants of CMTX.
Barrio LC; Castro C; Gómez-Hernandez JM
Ann N Y Acad Sci; 1999 Sep; 883():526-9. PubMed ID: 10586291
[No Abstract] [Full Text] [Related]
34. A novel Cx32 mutation causes X-linked Charcot-Marie-Tooth disease with brainstem involvement and brain magnetic resonance spectroscopy abnormalities.
Murru MR; Vannelli A; Marrosu G; Cocco E; Corongiu D; Tranquilli S; Cherchi MV; Mura M; Barberini L; Mallarini G; Marrosu MG
Neurol Sci; 2006 Apr; 27(1):18-23. PubMed ID: 16688595
[TBL] [Abstract][Full Text] [Related]
35. Corticospinal tract MRI hyperintensity in X-linked Charcot-Marie-Tooth Disease.
Kassubek J; Bretschneider V; Sperfeld AD
J Clin Neurosci; 2005 Jun; 12(5):588-9. PubMed ID: 16051098
[TBL] [Abstract][Full Text] [Related]
36. Clinical, electrophysiological and molecular genetic studies in a family with X-linked dominant Charcot-Marie-Tooth neuropathy presenting a novel mutation in GJB1 Promoter and a rare polymorphism in LITAF/SIMPLE.
Beauvais K; Furby A; Latour P
Neuromuscul Disord; 2006 Jan; 16(1):14-8. PubMed ID: 16373087
[TBL] [Abstract][Full Text] [Related]
37. Altered gene expression in Schwann cells of connexin32 knockout animals.
Nicholson SM; Gomès D; de Néchaud B; Bruzzone R
J Neurosci Res; 2001 Oct; 66(1):23-36. PubMed ID: 11598999
[TBL] [Abstract][Full Text] [Related]
38. GJB1 mutations c.212T>G and c.311A>C induce apoptosis and inwardly rectifying potassium current changes in X-linked Charcot-Marie-Tooth type 1.
Guo H; Liu Y; Gu J; Luo J; Ma Y; Xiao F
Biochem Biophys Res Commun; 2021 Dec; 582():8-15. PubMed ID: 34678594
[TBL] [Abstract][Full Text] [Related]
39. A V38A mutation in X-linked Charcot-Marie-Tooth neuropathy with unusual clinical features.
Karadima G; Panas M; Floroskufi P; Kalfakis N; Vassilopoulos D
J Neurol; 2004 Feb; 251(2):222-3. PubMed ID: 14991359
[No Abstract] [Full Text] [Related]
40. Point mutation associated with X-linked dominant Charcot-Marie-Tooth disease impairs the P2 promoter activity of human connexin-32 gene.
Wang HL; Wu T; Chang WT; Li AH; Chen MS; Wu CY; Fang W
Brain Res Mol Brain Res; 2000 May; 78(1-2):146-53. PubMed ID: 10891594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
